QUALITY ASSURANCE & QUALITY CONTROL OF BLOOD COMPONENTS

Slides:



Advertisements
Similar presentations
ADVANCED TECHNOLOGY IN BLOOD SEPARATION
Advertisements

QUALITY ASSURANCE IN THE BLOOD BANK
CBER Whole Blood and Blood Components Diane K. Hall Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
Blood Bag Coagulation & Preservers Citrate 24 hours 1-6 ºC Heparin 48 hours 1-6 ºC ACD or CPD 21 days 1-6 ºC CPD-A135 days 1-6 ºC CPD-A1+ additive.
Expectations Vs Achievements - Quality Control Of Blood Components
Blood Components Dosage And Their Administration
Blood products. Preparation of blood components. Whole blood plasma Backed Red Cells 90% waterRBC10% plasma material Fresh frozen plasma Platelet concentrate.
Components Preparation By: Wajnat Tounsi. Why preserve blood?! To provide patients who need blood components transfusion with VIABILE products. RBCs viability.
Blood products By Dr Sarah Rehman Date: 10/10/14.
Introduction of « TRIMA » in a Regional Blood Transfusion Organisation Dr Bernard LAMY.
Buffy Coat Method Platelet Poor Plasma Step 1: Whole Blood is collected into a top and bottom pack and is centrifuged (hard spin) to produce platelet poor.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Blood Components.
KEY CONCEPT Blood is a complex tissue that transports materials.
Blood Component Preparation and Therapeutic Utilization
Blood Components and Plasma derivatives
1 Massive Blood Transfusion Massive transfusion, defined as the replacement by transfusion of more than 50 percent of a patient's blood volume in 12 to.
Blood Components and Plasma derivatives
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
QUALITY ASSURANCE IN BLOOD BANKING
ISBT 128 Labelling Standard for Blood Components
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
BLOOD TRANSFUSION Begashaw M (MD).
Good Manufacturing Practices for Blood Establishments
Unit 2 Blood and Blood Components
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
Immunohematology (Blood Bank) CLS 245. What is Immunohematology? It is the study of Antigen-Antibody reaction as they relate to blood disorder.
TRANSFUSION MEDICINE MBBS,MCPS,FCPS. Professor of Pathology
1 Quality Control Procedures During Autotransfusion AmSECT New Advances in Blood Management Meeting Seattle, Washington September 8, 2011John Rivera.
GURU BRAHMA GURU VISHNU GURU DEVO MAHESWARAHA GURU SHATHSHATH
BLOOD COMPONENT THERAPY,RATIONALE USE OF BLOOD AND BLOOD PRODUCTS
CBER Red Blood Cell Immunization Programs Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Compatibility Testing (cross matching)
BLOOD COMPONENT PREPARATION
Blood Component Therapy
Apheresis Blood Components
IN THE NAME OF GOD Quality Assurance and Blood Bank S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO)
REGULATIONS FOR BLOOD and BLOOD PRODUCTS JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
UROOJ MUHAMMAD ISMAIL SYED ADNAN ALI WAHIDI NAJMA SOMROO NUZHAT HINA HINA KHAN SANAM QURBAN.
Compatibility Testing
Module 1: The Journey of Blood: Donation to Distribution Transfusion Training Workshop KKM 2012.
Module 2: Request for blood and blood components
FDA Update: Particulate Matter Task Force Sharyn Orton, Ph.D. OBRR/CBER/FDA Blood Products Advisory Committee Meeting June 19, 2003.
Concurrent and Component Plasma: CBER Considerations on Standards and Labeling BPAC April 28, 2011 Mark Weinstein, Ph.D. Office of Blood Research and Review.
The Massive Transfusion Protocol An Aide Memoire 1.
Preparation of blood components
Human Blood Groups The ABO System. Human Blood All humans have the same basic parts to their blood and this includes RBC, WBC, platelets and plasma. All.
lecture 10 blood bank Compatibility Testing
Practical of the First and Second Experiments
(Anticoagulant).
Sample Collection Bayer recommendations BNP is unstable in glass containers Recommended sample type is EDTA plasma using plastic tubes for sample collection.
10. Keep the donor under observation throughout the donation process. The donor should never be left unattended during or immediately after donation. 11.
Compatibility Testing
BLOOD & BLOOD PRODUCTS.
Introduction to Immunohematology
Blood Preservation and Storage
BLOOD COMPONENTS Prepared by Emmanuel H. Ndaki Lab Scientist (components prep) Head of Lab, Lake Zone Blood Transfusion center Mwanza. 23 November 2017.
BLOOD By: Sathish Rajamani Associate Professor. INTRODUCTION Blood is a connective tissue in fluid form. It is considered as the ‘Fluid of Life’, ‘fluid.
The Clinical Laboratory
KEY CONCEPT Blood is a complex tissue that transports materials.
Blood Group reagent evaluation
Intraoperative Cell Salvage
Goals Of Blood Collection
Blood Components MLAB 2431 Immunohematology
PERIOPERATIVE BLOOD TRANSFUSION
Process Control in a Component Laboratory
Blood Components Dosage And Their Administration
KEY CONCEPT Blood is a complex tissue that transports materials.
Presentation transcript:

QUALITY ASSURANCE & QUALITY CONTROL OF BLOOD COMPONENTS Syed Adnan Ali Cp = 10 .

INTRODUCTION Quality management is an integrated systems of quality assurance covering all matters which individually or collectively influence the components in order to guarantee their quality. Good Manufacturing Practice (GMP), quality control and audit programmed, all are closely linked together with the management of errors and accidents. Internal quality control and proficiency testing are aspects of quality system concerns with examination of material component and the proficiency of the staff

QC of blood component preparation Whole blood: Frequency of control: 1% of all units with minimum of 4 units per month Storage :- 2ºC to 6 ºC, for CPDA-1 the storage time is 35 days, CPD & CD2D – 22days. On expire date :- measure HCT, pH, total Hb , K+ and perform sterility assays

QA:- Volume : 450ml ± 10 % of body volume excluding anticoagulant HCT : 40±5% pH > 6.5 K < 27mmol/L Hb minimum 45g/unit Sterility : no growth

Red cell concentrates Perform the same assay as for Whole blood on the expiry date Storage : 2-6º C, for 35 days if prepared from WB collected in CPDA-1 QA: Volume : 280ml± 50ml, frequency of control 1% of all units HCT : 0.65-0.75 pH > 6.5 K < 78 mmol/L Hb : minimum 45g/unit Sterility : no growth

Platelet concentrates: Prepared within 6H of blood collection Must evaluate at least 4 platelet preparations monthly for platelet count,pH and plasma volume Platelets should be selected from each centrifuge in use The Tº at which pH is measured should be the same as stored Label the volume, the actual volume by measurement must be 10% of the stated volume Storage : 20-24ºC Tº should be recorded at least every 4H during storage.

QC Volume > 40ml pH : 6.8-7.4 Plt count : at least 5.5 x 1010 /bag in at least 75% of the units tested at the end of the storage. By apheresis : minimum 3 x 1011/bag platelets in at least 75% units tested WBC contamination: < 2 x 103/bag RBC contamination: < 2 x 109/bag Macroscopic appearance : no visible platelets aggregates Sterility : no growth

Fresh Frozen Plasma Every 10 unit/week estimate the volume Storage: 24 months at below –30ºC 12 months at –25 to –30ºC 3 months at –18 to –25ºC Thawed at Tº between 30-37ºC and transfused within 24H after thawing QC Volume: 220-250ml Factor VIIIc : > 0.7IU/ml- every 2 months No leakage after pressure in plasma extractor, before freezing and after thawing

QC Macroscopic : no abnormal color or visible clots Residual cell: Red cell: < 6.0 x 109/l Leukocyte: < 0.1 x 109/l Platelets : < 50 x 109/l

Cryoprecipitate Assayed on at least 4 bags/ month –for factor VIII Storage: 24 months at below –30ºC 12 months at –25 to –30ºC 3 months at –18 to –25ºC Must be thawed at 37ºC and used within 6H

QC Volume : 10-20 ml Factor VIII : > 70 IU/unit Fibrinogen : > 140 mg per unit Macroscopic : homogenous Sterility: no growth

Quality control for reagents Select the reagent with high specifications- reference preparation has been established for ABO, Rh and anti-human globulin (AHG) by FDA Color codes by the FDA: Blue for anti-A Yellow for anti-B Green for AHG Use according to manufacturer's instruction The new reagent has to be assessed & confirmed satisfactory The appearance each reagent has to be checked each day The reactivity and specificity has to checked each new lot

Reference: Guide to the preparation, use and quality assurance of blood components, 7th edition, Council of Europe Publishing Technical Manual American Association of Blood Banks, 11th edition

Thank You